Abbvie Inc [NYSE: ABBV] plunged by -$0.86 during the normal trading session on while it closed the day at $184.85.
Abbvie Inc stock has also loss -1.68% of its value over the past 7 days. However, ABBV stock has declined by -6.33% in the 3 months of the year. Over the past six months meanwhile, it has gained 8.97% and gained 4.02% year-on date.
The market cap for ABBV stock reached $326.52 billion, with 1.77 billion shares outstanding and 1.76 billion shares in the current float. Compared to the average trading volume of 8.17M shares, ABBV reached a trading volume of 5502858 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Abbvie Inc [ABBV]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ABBV shares is $214.88 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ABBV stock is a recommendation set at 1.90. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Citigroup have made an estimate for Abbvie Inc shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on May 14, 2025. While these analysts kept the previous recommendation, Cantor Fitzgerald raised their target price to Overweight. The new note on the price target was released on April 22, 2025, representing the official price target for Abbvie Inc stock. Previously, the target price had yet another raise to $191, while BofA Securities analysts kept a Neutral rating on ABBV stock.
The Average True Range (ATR) for Abbvie Inc is set at 6.10, with the Price to Sales ratio for ABBV stock in the period of the last 12 months amounting to 5.69. The Price to Book ratio for the last quarter was 229.93, with the Price to Cash per share for the same quarter was set at 2.93. Price to Free Cash Flow for ABBV in the course of the last twelve months was 21.22 with Quick ratio for the last quarter at 0.64.
ABBV stock trade performance evaluation
Abbvie Inc [ABBV] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.68. With this latest performance, ABBV shares gained by 8.63% in over the last four-week period, additionally plugging by 8.97% over the last 6 months – not to mention a rise of 12.47% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ABBV stock in for the last two-week period is set at 47.56, with the RSI for the last a single of trading hit 48.04, and the three-weeks RSI is set at 47.29 for Abbvie Inc [ABBV]. The present Moving Average for the last 50 days of trading for this stock 192.52, while it was recorded at 182.74 for the last single week of trading, and 189.30 for the last 200 days.
Abbvie Inc [ABBV]: An insightful look at the core fundamentals
Abbvie Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.64 and a Current Ratio set at 0.76.
Earnings per share (EPS) analysis for Abbvie Inc [ABBV] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ABBV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Abbvie Inc go to 15.20%.
Abbvie Inc [ABBV]: Institutional Ownership
The top three institutional holders of ABBV stocks are: VANGUARD GROUP INC with ownership of 170.66 million shares, which is approximately 9.6472%. BLACKROCK INC., holding 136.43 million shares of the stock with an approximate value of $$23.4 billion in ABBV stocks shares; and BLACKROCK INC., currently with $$13.34 billion in ABBV stock with ownership which is approximately 4.398%.
